| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 47,332 | 31,123 | ||
| Accounts receivable | 550 | 373 | ||
| Inventory | 486 | 505 | ||
| Prepaid expenses, deposits, and other current assets | 1,474 | 1,832 | ||
| Total current assets | 49,842 | 33,833 | ||
| Fixed assets, net | 862 | 948 | ||
| Operating lease right-of-use assets | 2,021 | 2,238 | ||
| Intangible assets, net | 421 | 526 | ||
| Other assets | 52 | 1,125 | ||
| Total assets | 53,198 | 38,670 | ||
| Accounts payable | 751 | 833 | ||
| Accrued expenses and other current liabilities | 2,277 | 2,422 | ||
| Operating lease liabilities, current portion | 878 | 871 | ||
| Senior secured convertible notes - at fair value | 22,300 | 25,300 | ||
| Total current liabilities | 26,206 | 29,426 | ||
| Operating lease liabilities, less current portion | 1,157 | 1,382 | ||
| Total liabilities | 27,363 | 30,808 | ||
| Preferred stock, 0.001 par value, 20,000,000 shares authorized series b and series b-1 convertible preferred stock, issued and outstanding 54,274 and 54,419 as of september 30, 2025 and december 31, 2024, respectively | 54,274 | 54,419 | ||
| Common stock, 0.001 par value, 300,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 130,924,686 and 63,071,950 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 131 | 102 | ||
| Additional paid-in capital | 229,499 | 201,013 | ||
| Accumulated deficit | -258,069 | -247,672 | ||
| Total stockholders equity (deficit) | 25,835 | 7,862 | ||
| Total liabilities and stockholders equity (deficit) | 53,198 | 38,670 | ||
Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc. (LUCD)